Loading…
To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes.
Legislative Progress
Introduced
September 28, 2017
Latest Action
September 29, 2017
Primary Sponsor
Markwayne MullinRepublican(OK)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
37pct
1d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
This bill amends title XVIII (Medicare) of the Social Security Act to establish two care-management demonstration programs for chronic kidney disease (CKD) under the Medicare program: (1) the CKD Early Detection and Treatment Demonstration Program, and (2) the Demonstration Program for Advanced CKD. A practitioner's participation in either program shall be optional. Through each program, the Centers for Medicare & Medicaid Services (CMS) shall provide to an enrollee's participating primary-care practitioner a single, monthly, performance-based payment for covered CKD care-management services furnished to the enrollee. The amount of this payment shall be greater than the amount that the practitioner would otherwise have received under Medicare for furnishing such services to the enrollee. The CMS shall specify applicable performance measures, in accordance with clinical guidelines.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2018 · fourth_quarter · Medicare/Medicaid
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867). Proposed Alternative Payment Model for Chronic Kidney Disease care. Comments on Efficiency and Transparency Transplant Conditions of Participation, including organ discards. Comments on Proposed Rule Making for Part B drugs. Medicare Part D Protected Classes status. Increased utilization of home kidney dialysis. Medicare coverage of immunosuppressive drugs for kidney transplant recipients.
Client expense: $100,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · fourth_quarter · Health Issues
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · fourth_quarter · Medicare/Medicaid
promoting payment policies that promote early detection and treatment of chronic kidney disease; ensuring patient access to care that improves outcomes and patients with chronic kidney disease; H.R. 3867 - a bill to establish a pilot program within the Department of Health and Human Services (HHS) that encourages practitioners to identify early symptoms of chronic kidney disease (CKD), lowering overall health care costs and providing better treatment for patients with CKD. HR 1270 - the Living Donor Protection Act; FY2019 Labor HHS Appropriations bill
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · fourth_quarter · Health Issues
Chronic kidney disease, end-stage renal disease Medicare payment and quality, drug shortages; HR 1270, Living Donor Protection Act; Medicare physician payment; immunosuppressive drug coverage; Dialysis Patients Demonstration Act HR 3867 CKD Demonstration Program
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Health Issues
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · third_quarter · Medicare/Medicaid
promoting payment policies that promote early detection and treatment of chronic kidney disease; ensuring patient access to care that improves outcomes and patients with chronic kidney disease; H.R. 3867 - a bill to establish a pilot program within the Department of Health and Human Services (HHS) that encourages practitioners to identify early symptoms of chronic kidney disease (CKD), lowering overall health care costs and providing better treatment for patients with CKD. HR 1270 - the Living Donor Protection Act; FY2019 Labor HHS Appropriations bill
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · third_quarter · Health Issues
Chronic kidney disease, end-stage renal disease Medicare payment and quality, drug shortages; HR 1270, Living Donor Protection Act; Medicare physician payment; immunosuppressive drug coverage; Dialysis Patients Demonstration Act HR 3867 CKD Demonstration Program
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Medicare/Medicaid
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Proposed Alternative Payment Model for Chronic Kidney Disease care Comments on ESRD Prospective Payment System and Quality Incentive Program proposed rule Comments on payment policies under the Physician Fee Schedule; Medicare Shared Savings Program; and Quality Payment Program Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Client expense: $100,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Health Issues
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · second_quarter · Health Issues
Chronic kidney disease, end-stage renal disease Medicare payment and quality, drug shortages; HR 1270, Living Donor Protection Act; Medicare physician payment; immunosuppressive drug coverage; Dialysis Patients Demonstration Act HR 3867 CKD Demonstration Program
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Medicare/Medicaid
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Client expense: $100,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Medicare/Medicaid
promoting payment policies that promote early detection and treatment of chronic kidney disease; ensuring patient access to care that improves outcomes and patients with chronic kidney disease; H.R. 3867 - a bill to establish a pilot program within the Department of Health and Human Services (HHS) that encourages practitioners to identify early symptoms of chronic kidney disease (CKD), lowering overall health care costs and providing better treatment for patients with CKD. HR 1270 - the Living Donor Protection Act; FY2019 Labor HHS Appropriations bill
Client expense: Not reported · Firm income: $40,000
2018 · first_quarter · Health Issues
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · first_quarter · Medicare/Medicaid
promoting payment policies that promote early detection and treatment of chronic kidney disease; ensuring patient access to care that improves outcomes and patients with chronic kidney disease H.R. 3867 - a bill to establish a pilot program within the Department of Health and Human Services (HHS) that encourages practitioners to identify early symptoms of chronic kidney disease (CKD), lowering overall health care costs and providing better treatment for patients with CKD.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Medicare/Medicaid
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Comments to CMS regarding Medicare Advantage and Part D Annual Notice and Call Letter Peer Mentoring collaboration with CMS
Client expense: $100,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
2018 · first_quarter · Health Issues
Chronic kidney disease, end-stage renal disease Medicare payment and quality, drug shortages; HR 1270, Living Donor Protection Act; Medicare physician payment; immunosuppressive drug coverage; Dialysis Patients Demonstration Act HR 3867 CKD Demonstration Program
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2017 · fourth_quarter · Health Issues
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes Dialysis PATIENTS Demonstration Act of 2017
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · fourth_quarter · Medicare/Medicaid
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Submitted Alternative Payment Model proposal for CKD care to CMS and HHS Comments to CMS on Dialysis Facility Compare
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
2017 · fourth_quarter · Medicare/Medicaid
promoting payment policies that promote early detection and treatment of chronic kidney disease; ensuring patient access to care that improves outcomes and patients with chronic kidney disease H.R. 3867 - a bill to establish a pilot program within the Department of Health and Human Services (HHS) that encourages practitioners to identify early symptoms of chronic kidney disease (CKD), lowering overall health care costs and providing better treatment for patients with CKD.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Medicare/Medicaid
promoting payment policies that promote early detection and treatment of chronic kidney disease; ensuring patient access to care that improves outcomes and patients with chronic kidney disease H.R. 3867 - a bill to establish a pilot program within the Department of Health and Human Services (HHS) that encourages practitioners to identify early symptoms of chronic kidney disease (CKD), lowering overall health care costs and providing better treatment for patients with CKD.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Health Issues
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patient Living Donor Protections Hospital Readmissions & Transplant Patients Federal Funding for Medical Research H.R.3867 - To amend title XVIII of the Social Security Act to create care management demonstration programs for chronic kidney disease under the Medicare program, and for other purposes
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · third_quarter · Medicare/Medicaid
Urge Congress to provide access to Medigap plans for all ESRD patients under 65 years (Support H.R. 2644/S.1890); Protect dialysis patient access to charitable premium assistance (Support H.R. 3976); Ensure ESRD patients retain access to commercial insurance and tax subsidies; Support ESRD care coordination - the Dialysis PATIENTS Act; Encourage support for improved kidney research and treatment (Support H.R. 3867); and Support expanding access to telehealth and home dialysis.
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Health Issues
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
2017 · third_quarter · Medicare/Medicaid
promoting payment policies that promote early detection and treatment of chronic kidney disease; ensuring patient access to care that improves outcomes and patients with chronic kidney disease H.R. 3867 - a bill to establish a pilot program within the Department of Health and Human Services (HHS) that encourages practitioners to identify early symptoms of chronic kidney disease (CKD), lowering overall health care costs and providing better treatment for patients with CKD.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| NC |
| David Young | Republican | IA |
| Donald M. Payne, Jr. | Democratic | NJ |
| Earl Blumenauer | Democratic | OR |
| G. K. Butterfield | Democratic | NC |
| George Holding | Republican | NC |
| James A. Himes | Democratic | CT |
| James P. McGovern | Democratic | MA |
| Larry Bucshon | Republican | IN |
| Leonard Lance | Republican | NJ |
| Linda T. Sánchez | Democratic | CA |
| Mark DeSaulnier | Democratic | CA |
| Peter J. Visclosky | Democratic | IN |
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE